Press Releases

Press Releases

BusinessWire | December 11, 2017
Quanterix Corporation (NASDAQ:QTRX), a company with a next generation, ultra-sensitive digital platform that advances precision health, today announced the closing of its initial public offering of 4,916,480 shares of common stock at a public offering price of $15.00 per share, including 641,280…
Nasdaq | December 07, 2017
Quanterix Corporation (Nasdaq:QTRX), a company with a next generation, ultra-sensitive digital platform that advances precision health, will visit the Nasdaq MarketSite in Times Square.
Business Wire | December 06, 2017
Today Quanterix announced the pricing of its initial public offering of 4,275,200 shares of its common stock at a public offering price of $15.00 per share for aggregate gross proceeds of $64,128,000. In addition, Quanterix has granted the underwriters a 30-day option to purchase up to 641,280…
Business Wire | November 10, 2017
New technology unlocks ultra-sensitive biomarker detection with the potential to advance the diagnosis and treatment of neurological diseases
CAMBRIDGE, MA – August 25, 2008 – Quanterix Corporation, the leader in single molecule detection, announced today that it has closed the second tranche of its Series A round, bringing the total Series A financing amount to $15 million. Proceeds from the financing will be used to validate the…
CAMBRIDGE, MA – December 17, 2010 – Quanterix, a single molecule diagnostics company providing technology with unprecedented sensitivity for the life science and in vitro diagnostics markets, today announced that David Okrongly, Ph.D., President and Chief Executive Officer, will present at the 3rd…
CAMBRIDGE, MA – September 19, 2011 – Quanterix Corporation, using its revolutionary Single Molecule Array (SiMoA™) technology to enable unprecedented high value research and diagnostic products based on its ultrasensitive protein detection platform, announced today that Martin D. Madaus, Ph.D has…
LEXINGTON, MA – July 20, 2012 – Quanterix Corporation, developer of the Single Molecule Array (Simoa) technology, announced today that it has appointed Paul Chapman as its new President and Chief Executive Officer. Mr. Chapman joins the company at a pivotal time, as it moves from development to…
LEXINGTON, Mass., September 17, 2013 – delivering the world’s most sensitive single molecule immunoassay measurement for the benefit of human health, today announced its recently published Multiplexed Single Molecule Immunoassays study that successfully demonstrated the ability to measure multiple…
Lexington--(BUSINESS WIRE)– May 28, 2014 Quanterix, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, announced today it has been selected as a Red Herring Top 100 North America award winner. The Top 100 award winners are…